<DOC>
	<DOCNO>NCT00024297</DOCNO>
	<brief_summary>RATIONALE : Warfarin may effective prevent formation blood clot patient central venous catheter . PURPOSE : Randomized clinical trial study effectiveness warfarin prevent blood clot cancer patient central venous catheter .</brief_summary>
	<brief_title>Warfarin Preventing Blood Clots Cancer Patients With Central Venous Catheters</brief_title>
	<detailed_description>OBJECTIVES : - Determine utility warfarin reduce thrombosis rate cancer patient central venous catheter . - Compare thrombosis rate patient treat different warfarin dosing schedule . - Compare adverse event survival patient receive receive drug . OUTLINE : This randomize , multicenter study . Patients stratify accord sclerosant potential cytotoxic regimen ( low vs high ) , site placement catheter ( peripheral v central ) , duration drug administration ( brief infusion ( 24 hour ) vs prolong infusion ( 24 hour ) ) . Patients randomize 1 3 arm . - Arm I : Patients receive warfarin . - Arm II : Patients receive oral warfarin daily begin 3 day placement central venous catheter ( CVC ) continue CVC remove thrombosis occurs . - Arm III : Patients receive oral warfarin arm II , dose adjustment CVC placement achieve maintain INR level . Patients follow 12 month . PROJECTED ACCRUAL : A total 1,400 patient ( 400 arm I , 700 arm II , 300 arm III ) accrue study within 2 year .</detailed_description>
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically confirm cancer Planned placement central venous catheter ( CVC ) administration chemotherapy No use CVC additional purpose except antibiotic therapy blood product PATIENT CHARACTERISTICS : Age : 16 Performance status : Not specify Life expectancy : Not specify Hematopoietic : WBC least 2,000/mm3 Platelet count least 100,000/mm3 Hemoglobin least 10 g/dL No congenital bleed disorder Hepatic : Not specify Renal : Not specify Other : No contraindication warfarin No anatomic lesion bleed ( e.g. , duodenal ulcer ) Not pregnant nursing Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy See Disease Characteristics Endocrine therapy Not specify Radiotherapy Not specify Surgery Not specify Other No prior enrollment study No concurrent therapy would interfere study drug No concurrent warfarin</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2002</verification_date>
	<keyword>thromboembolism</keyword>
</DOC>